MARKSANS PHARMA
Back to All Ratios
|
MARKSANS PHARMA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | 27.69 | 32.55 | -13.16 | 79.82 | 40.81 |
What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?
Year | Core EBITDA Growth |
---|---|
Mar2024 | 27.69 |
Mar2023 | 32.55 |
Mar2022 | -13.16 |
Mar2021 | 79.82 |
Mar2020 | 40.81 |
How is Core EBITDA Growth of MARKSANS PHARMA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2024 | 27.69 | -14.93 | |
Mar2023 | 32.55 | Positive | |
Mar2022 | -13.16 | Negative | |
Mar2021 | 79.82 | 95.59 | |
Mar2020 | 40.81 | - |
Other Financial Ratios of MARKSANS PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹13,120.1 Cr | -5% | -15% | 62.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹444,873.0 Cr | -1.9% | 2.7% | 42.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,544.0 Cr | -2.9% | -3.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,964.0 Cr | -2.2% | 1.4% | 14.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,710.0 Cr | -1.4% | 7.8% | 13.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,744.0 Cr | 2.8% | 0.6% | 35.5% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -5% |
-15% |
62.5% |
SENSEX | 0.1% |
-4.4% |
8.8% |
You may also like the below Video Courses